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The activity of Ras is controlled by the interconversion
between GTP- and GDP-bound forms partly regulated by the
binding of the guanine nucleotide exchange factor Son of Sev-
enless (Sos). The details of Sos binding, leading to nucleotide
exchange and subsequent dissociation of the complex, are not
completely understood. Here, we used uniformly 15N-labeled
Ras as well as [13C]methyl-Met,Ile-labeled Sos for observing
site-specific details of Ras-Sos interactions in solution. Binding
of various forms of Ras (loaded with GDP andmimics of GTP or
nucleotide-free) at the allosteric and catalytic sites of Sos was
comprehensively characterized by monitoring signal perturba-
tions in the NMR spectra. The overall affinity of binding
between these protein variants as well as their selected func-
tional mutants was also investigated using intrinsic fluores-
cence. The data support a positive feedback activation of Sos by
RasGTP with RasGTP binding as a substrate for the catalytic
site of activated Sos more weakly than RasGDP, suggesting
that Sos should actively promote unidirectional GDP 3 GTP
exchange on Ras in preference of passive homonucleotide
exchange. RasGDP weakly binds to the catalytic but not to the
allosteric site of Sos. This confirms that RasGDP cannot prop-
erly activate Sos at the allosteric site. The novel site-specific
assay described may be useful for design of drugs aimed at per-
turbing Ras-Sos interactions.
Ras proteins are mutated in 30% of all human tumors, con-
tributing to several malignant phenotypes, including abnormal
cell growth, proliferation, and apoptosis (1). The activity of Ras
is controlled by the interconversion between GTP- and GDP-
bound formswithGTP binding required for the active form (2).
Ras activation is mediated through the binding of guanine
nucleotide exchange factors of which themost important is Son
of Sevenless (Sos),5 which stimulates the release of bound GDP
from Ras and is currently thought to facilitate the more abun-
dant cytosolic GTP to bind in its place (3). The major Ras iso-
forms, H-Ras, K-Ras, and N-Ras, are closely related, bearing
85% amino acid sequence identity; however, 85% of clinically
observed Ras mutations occur in K-Ras (4). Point mutations at
codon 12 impair the GTPase activity of Ras isoforms both by
preventing productive binding of GTPase-activating proteins
that accelerate GTP hydrolysis and by suppressing intrinsic
(basal)GTPhydrolase activity. The single pointmutationG12V
in K-Ras, which is a common variant found in human tumors,
causes constitutive activation of Ras (5). This leads to an accu-
mulation of the GTP-bound active form of K-Ras (6).
Over the last few decades, studies have shown that several
regions of Ras are of particular interest for control of its func-
tional cycle and present potential intervention sites for new
therapeutics (4–7). The P-loop (residues G10–S17) is respon-
sible for phosphate binding, whereas the Switch I (Y32–Y40)
and Switch II (G60–T75) regions are critical for interactions
with guanine nucleotide exchange factors (7) and effector pro-
teins (8). Sos contains two domains that are essential for Ras
nucleotide exchange, namely the Ras exchanger motif domain
and the Cdc25 domain. The latter contains the catalytic site in
which bound Ras undergoes nucleotide exchange (9, 10). A sec-
ond Ras molecule binds at a distal (also called allosteric) site,
which is located between the Ras exchanger motif and Cdc25
domains. Binding of RasGTP to the allosteric site induces a
conformational change that is propagated to the catalytic site
(10–12), enhancing the rate of Ras nucleotide exchange activity
by increasing the affinity of Ras at the catalytic site. However, it
remains unclearwhether or towhat extentGDP-loadedRas can
allosterically activate Sos (11–13) and whether different forms
of Ras bind at the catalytic site of activated Sos equallywell. One
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(allosteric) site causes basal activation of Sos for further cata-
lytic site binding (11) with stronger RasGTP binding at the
distal site promoting a significantly higher level of activation,
resulting in a positive feedback activation mechanism (10–12).
Additionally, the binding at the allosteric site (and hence the
activation of Sos) is regulated and autoinhibited by interactions
with neighboring histone, Dbl homology (DH), and pleckstrin
homology (PH) domains of Sos (11, 14).
Currently, nucleotide exchange at the catalytic site is pre-
sumed to be passive: GDP is exchanged forGTP driven through
the higher cytosolic concentration ofGTP (3). For convenience,
currently used nucleotide exchange assays often quantify the
homonucleotide exchange, GDP3 GDP or GTP3 GTP, as a
measure of biological activity of Sos (10, 11, 13). However, it is
unclear whether or how rebinding of GDP or GTP to nucle-
otide-free Ras (a presumed transition state) at the catalytic site
of Sos occurs and how this triggers the dissociation of Ras upon
completion of nucleotide exchange, allowing Sos to engage in
further cycles of guanine nucleotide exchange factor activity.
Binding of RasGTP at the allosteric site and thus activation of
Sos increases affinity of RasGDP binding at the catalytic site
with a measured Kd of 1.9 M (11), but to our knowledge, the
affinity of RasGTP binding to the catalytic site of activated Sos
has not been reported to date.
Themodel of Sos activation by binding of Ras to the allosteric
site is based on static snap shots from x-ray crystal structures
(10, 11) and therefore may not fully represent the dynamic sub-
tleties of the process in solution. Indeed, recent singlemolecule
studies have suggested a critical role for dynamic fluctuations in
the allosteric activation of Sos by RasGTP and hinted at the
possibility that RasGDP can also activate Sos (13). How these
fluctuations are modulated at a detailed structural level and
whether RasGDP can bind with sufficient affinity to the allos-
teric site to activate Sos remain to be established.
Previous solution NMR studies, which can capture the
dynamic behavior of proteins, have explored the process of
GTP hydrolysis and nucleotide exchange in H-Ras (15–17).
Other studies were able to demonstrate that H-Ras interacts
with its downstream effector proteins such as Raf kinases (18–
20). Studies using 31P NMR spectroscopy revealed that the
GTP-bound form of Ras is likely to exist in two ormore confor-
mational states that interconvert on the millisecond time scale
(21). The conformational equilibrium can be shifted by intro-
ducing point mutations that enhance the affinity of GTP-Ras
for Raf kinases (21–25).
To our knowledge, no detailed solution studies of the Ras-
Sos interactions using NMR spectroscopy have yet been
reported. Here, we used NMR to dissect Ras-Sos interactions.
Signal perturbations were used to monitor changes in Ras and
Sos upon binding, depending on their stoichiometry and type of
nucleotide present.Moreover, we introduced a number of non-
perturbing probes (13C-labeled methyls of methionines (26))
into Sos and used them tomonitor Ras binding separately to the
allosteric and catalytic sites. Using intrinsic fluorescence, we
also measured the binding affinity to Sos of wild-type (WT) as
well as functional mutants of Ras in various nucleotide-loaded
forms. Our data have enabled us to disentangle the binding
preferences of GTP- and GDP-loaded forms of Ras in solution
at the specific sites on Sos.
Experimental Procedures
Protein Expression and Purification—H-Ras (residues
1-166), K-Ras (residues 1–166), SosCat (residues 563–1049),
and SosHD-DH-PH-Cat (residues 1–1049) gene sequences were
synthesized by Geneart (Life Technologies) and cloned into a
pET28b vector with an N-terminal His6 tag followed by a
tobacco etch virus protease cleavage site prior to the protein
sequence. Proteins were expressed in BL21-GOLD(DE3) com-
petent cells, and the seeder cultures were grown in Luria broth
(LB) medium. All samples were grown using a similar protocol
(27) for unlabeled and uniformly 15N-labeled H-Ras samples.
WT and mutant Sos constructs (SosCat and SosHD-DH-PH-Cat)
were grown inminimalM9medium containing 50g/ml kana-
mycin and 12.5 g/ml tetracycline antibiotics supplemented
with micronutrients and vitamins. Cells were then induced by
0.1 mM isopropyl -D-1-thiogalactopyranoside followed by the
addition of 2 g/liter D-glucose. Uniformly recombinant SosCat
13C-labeled at the Met (-) and Ile (1-)methyl positions ([13C-
methyl-Met,Ile]SosCat) was produced under a similar protocol
in D2O but with an additional feed of 200mg/liter [13C]methyl-
Met, 120 mg/liter [13C]methyl--ketobutyrate, and 2 g/liter
d7-D-glucose administered at the point of isopropyl-D-1-thio-
galactopyranoside induction. Protein purification was carried
out as described previously (27). Unless stated otherwise, all
proteins were cleaved from their N-terminal His6 tags using
tobacco etch virus protease.
Nucleotide Exchange in Ras Samples—Purified H-Ras sam-
ples were incubatedwith a 20-fold excess of GTPS, GppNp, or
GppCp and 1⁄100-fold His-tagged Sos in 50 mM Hepes, 50 mM
NaCl, 2 mM MgCl2, 2 mM tris(2-carboxyethyl)phosphine, 0.1
mM EDTA, 0.02% NaN3 at pH 7.4. The samples were left over-
night at 4 °C to allow nucleotide exchange. The mixture was
then passed through a nickel-nitrilotriacetic acid column equil-
ibratedwith 30mMNa2HPO4, 1mMDTT, 2mMMgCl2, 0.1mM
EDTA, 0.02% NaN3 at pH 7.0 to remove the His6-tagged Sos
and free nucleotide. The samples were concentrated using
0.5-ml VivaSpin concentrators (Sartorius; 10,000 molecular
weight cutoff). Protein concentration was determined by stan-
dard Bradford assays. Nucleotide exchange was confirmed by
electrospray mass spectrometry. For the preparation of the
nucleotide-free form of Ras (hereafter referred to as H-RasNF),
H-RasGDP (200 M) sample was incubated with 20 mM EDTA
to strip theMg2 andnucleotide fromRas.After 2 h, the sample
was passed down a pre-equilibratedNap-5 column (GEHealth-
care) to exchange the sample into Hepes buffer, pH 7.4, con-
taining 50 mM L-Arg and L-Glu to improve sample stability for
the duration of NMR measurements (28). H-RasNF was then
concentrated down as required using an Amicon Ultra-15 cen-
trifugal filter unit (Millipore) with a 10,000 molecular weight
cutoff.
NMRExperiments—All NMR spectra were collected at 298K
(unless stated otherwise) on Bruker 600- and 800-MHz
(Avance I and III, respectively) spectrometers equipped with
5-mm TCI CryoProbes with z-axis gradients using standard
experiments and parameters from the Bruker library. Uni-
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formly 15N-labeled H-Ras was used at a concentration of 100
M, and [13C-methyl-Met,Ile]SosCat was used at 60 M with
concentrations of added non-labeled protein variants as indi-
cated.NMRsamples containing proteins or theirmixtureswere
prepared in either phosphate buffer at pH 7.0 orHepes buffer at
pH 7.4 supplemented with 5% D2O and placed in a Shigemi
tube. All spectra were processed in Topspin 2.1 or 3.1 and ana-
lyzed in NMRViewJ (29).
Measuring Affinities of Ras-Sos Interactions—Fluorescence
binding assays were performed using a luminescence spec-
trometer (PerkinElmer Life Sciences) with emission and exci-
tation slits set to 3 and 10 nm, respectively. Samples were mea-
sured in 1-ml quartz cuvettes with path lengths of 1 and 0.4 cm
used for excitation (295 nm) and emission (336 nm), respec-
tively. Data points were taken in quadruplicate with a scan
speed of 300 ns/min. WT SosCat or SosHD-DH-PH-Cat samples
(10 M) were incubated with increasing amounts of Ras (1–50
M) in Hepes buffer. To obtain the dissociation constant of
binding (Kd), the quenching of intrinsic fluorescence of the Trp
residues in Sos upon addition of the non-fluorescent Ras pro-
tein wasmonitored. The weak contribution of intrinsic fluores-
cence of Ras as well as the change in fluorescence due to dilu-
tion effects were taken into account and compensated for.
Fluorescence experiments were repeated three times. Data
points were fitted (change in fluorescence versus Ras concen-
tration) using non-linear regression to a standard quadratic
binding equation using GraFit (30).
Results
Fluorescence Measurements—The overall apparent binding
affinities of Ras to Sos were determined by monitoring the
change (i.e. quenching) in Sos fluorescence upon the formation
of the Ras/Sos complex (Fig. 1). This approach relied on the
strong intrinsic fluorescence signal of themultiple Trp residues
within the SosCat and SosHD-DH-PH-Cat. Ras is devoid of Trp
residues, and therefore its intrinsic fluorescence signal at 295
nm is negligible. To determine the affinities accurately, the
minor dilution effect and the background fluorescence of Ras
(without Sos) were further subtracted from the overall fluores-
cence. First, we explored the differences in binding of the iso-
forms H-Ras and K-Ras as well as K-RasG12V, a common can-
cer-associated mutant, to Sos when Ras was loaded with
different stable analogs of GTP. Traditionally, nucleotide
exchange has been studied using fluorescently labeled analogs
such as mantGTP (11, 14, 31); however, the bulky mant adduct
has been shown to affect the kinetics of nucleotide exchange
and hydrolysis in H-Ras (16, 23). For these reasons, we used
unlabeled slowly or non-hydrolyzable GTP mimics (GTPS,
FIGURE 1.Change in intrinsic fluorescence signal of SosCat variants upon addition of protein ligands, used to determine the dissociation constantsKd
presented in Table 1. Individual panels show binding of WT SosCat with H-RasGDP (A), H-RasGTPS (B), H-RasGppNp (C), H-RasGppCp (D), or
H-RasY64AGTPS (E) and binding of SosCatW729E with H-RasGTPS (F), SosHD-DH-PH-Cat with H-RasGTPS (G), SosCatW729E with H-RasY64AGTPS (H),
SosCatW729Ewith H-RasGDP (I), WT SosCat (preloadedwith 30MH-RasY64AGTPS) with H-RasGTPS (J), WT SosCat with K-RasGTPS (K), andWT SosCat with
K-RasG12VGTPS (L). The fluorescence data were fitted to a single site binding model using GraFit software (30). a.u., arbitrary units.
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GppNp, and GppCp) in our study coupled with measurement
of intrinsic protein fluorescence. Dissociation constants (Kd)
for interactions of H-RasGTPS, H-RasGppNp, and
H-RasGppCp with SosCat are generally very similar to each
other (5–8 M) (Table 1). Conversely, the affinity of
H-RasGDP for SosCat is10-fold weaker (Kd 54 M) (Table
1). These results are in agreement with the affinities previously
measured for RasGDP binding at the allosteric site of non-
activated Sos (11). In addition, the binding of K-RasGTPS to
SosCat (Kd  10  1 M) is stronger than the binding of
K-RasG12VGTPS (Kd  31  2 M) but comparable with
binding affinities of H-Ras loaded with GTP analogs (Table 1).
This suggests that WT K-Ras and H-Ras have fairly similar
Sos binding properties, whereas the oncogenic mutation
K-RasG12V has reduced binding affinity to Sos.
To assess the affinity of Ras binding specifically at the cata-
lytic site of Sos (when Sos is not activated), we set up further
experiments so that the allosteric site of Sos was either
obstructed, as in the SosHD-DH-PH-Cat variant, or disrupted by
mutation, as in SosCatW729E (10–12, 14, 32, 33). The affinity of
H-RasGTPS for SosHD-DH-PH-Cat (Kd  24 M) and for
SosCatW729E (Kd  28 M) is significantly weaker than
H-RasGTPS binding toWT SosCat (Kd 5 M; Table 1). The
binding of H-RasGDP to SosCatW729E (Kd 67M) is weaker
than the binding ofH-RasGTP to the same construct (Table 1).
Interestingly, when the allosteric site of SosCat is partially
saturated by the addition of excess H-RasY64AGTPS, a
mutant that cannot bind to the catalytic site of Sos (11), the
fluorescence measurements reveal that the binding of WT
H-RasGTPS at the catalytic site is weak with an observed Kd
of 21 M (Table 1). This value provides an upper limit estimate
for the binding affinity to the catalytic site as much of the
observed affinity may be due to competition between the Ras
forms for the allosteric site. Although the addition of
RasY64AGTPS in this experiment was expected to activate
Sos for further catalytic site binding (11, 12), our results suggest
that H-RasGTPS has only amodest-to-weak affinity (Kd 21
M) for the catalytic site of Sos. This result complements earlier
studies in which loading of H-RasY64AGppNp at the allosteric
site was found to increase the affinity for RasGDP at the cata-
lytic site with a Kd of 1.9 M (11). GppNp is another analog of
GTP with functional properties similar to those of GTPS (see
Table 1). The weaker binding observed for RasGTP at the cat-
alytic site has not been described previously and is significant as
it implies that RasGTP-activated Sos preferentially binds
RasGDP at its catalytic site but not RasGTP. This suggests a
clear preference of activated Sos for the heteronucleotide
exchange reaction GDP3 GTP at its catalytic site, which we
believe has not been recognized previously.
The binding of mutant H-RasY64A (Kd  10 M) to SosCat
was marginally weaker but comparable with WT H-Ras, sug-
gesting that this mutant and the wild-type protein have similar
binding properties when they are loaded with GTPS, and both
of them preferentially bind to the allosteric site. Attempts to fit
the quantitative binding data to a two-site model found no sig-
nificant improvement in the fit over the simpler one-site
models and are in agreement with RasGTPS preferentially
interacting at only one, namely the allosteric, site. To study the
site-specific binding of Ras with Sos further, we monitored
these interactions using NMR spectroscopy.
Monitoring NMR Signal Perturbations of H-Ras upon Bind-
ing to Different Nucleotides and Sos—First, the previous 1HN
and 15N backbone assignments of Ras residues 1–166 (17, 27)
were transferred to spectra of nucleotide-loaded and nucleo-
tide-free states to achieve their partial assignment for a number
of signals used as reporters. Amide signal perturbations of the
GDP- and GTP-bound forms of uniformly 15N-labeled H-Ras
were then monitored by acquiring 1H,15N correlation TROSY
spectra upon the addition of unlabeled SosCat (Fig. 2). The influ-
ence of the nucleotide in maintaining the structural integrity
of H-Ras was also investigated by comparing the spectra of
H-RasNF with the nucleotide-loaded forms H-RasGDP and
H-RasGTPS (Fig. 2).
The addition of unlabeled WT SosCat to the 15N-labeled
H-RasNF sample at a stoichiometry of 2:1 (Ras:Sos) showed
clear signal perturbations for a number of Ras residues and
the reappearance of two amide peaks belonging to residues
C118 and T124 (Fig. 3A). These signals, which became some-
what broadened for unbound nucleotide-free RasNF, recov-
ered for RasNF bound to Sos in positions similar to the GDP-
loaded form. The chemical shifts were generally comparable
with those caused by GDP binding to H-RasNF. Overall, this
result confirms that H-RasNF and Sos are able to form a
complex in solution, and this binding affects Ras dynamics.
TABLE 1
Summary of macroscopic dissociation constants for Ras/Sos complexes measured by fluorescence
Protein variants used for each titration experiment as well as a brief description of the expected functional effect of mutation are indicated.
Description of expected effect of mutation used Sos variant presenta Ras variant added Measured Kd
M
None SosCat H-RasGDP 54 4
None SosCat H-RasGTPS 5.0 0.8
None SosCat H-RasGppNp 6.0 0.9
None SosCat H-RasGppCp 8.0 1.0
Is not expected to bind at catalytic site SosCat H-RasY64AGTPS 10 1
Binding expected to be hindered at allosteric site SosCatW729E H-RasGTPS 28 1
Binding expected to be hindered at allosteric site SosHD-DH-PH-Cat H-RasGTPS 24 2
Binding expected to be hindered at both sites of Sos SosCatW729E H-RasY64AGTPS 32 3
Binding expected to be hindered at allosteric site SosCatW729E H-RasGDP 67 2
H-RasY64AGTPS expected to partially saturate allosteric site SosCat (preloaded with 30 M H-RasY64AGTPS) H-RasGTPS 21 2b
None SosCat K-RasGTPS 10 1
Oncogenic variant SosCat K-RasG12VGTPS 31 2
a Unless stated otherwise, the WT version of protein was used.
b Lower limit estimate.
Monitoring Ras-Sos Interactions
1706 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 4•JANUARY 22, 2016
 at U
N
IV
ERSITY
 O
F LEED
S on A
pril 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
FIGURE 2. Differences between H-Ras states in the 1H,15N TROSY spectra. A, comparison between H-RasGDP (blue) and H-RasNF (red). B, comparison
between H-RasGDP (blue) and H-RasGTPS (pink). C, spectra of H-Ras bound to GDP (blue), H-RasNF (red), and H-RasNF bound to Sos (green) in a 2:1 Ras:Sos
stoichiometry. D, spectra of H-RasGDP (blue) and H-RasGDP/Sos (green) in a 2:1 Ras:Sos stoichiometry. Spectra in A–Dwere collected at 25 °C. E, comparison
among H-RasGDP (blue), H-RasGTPS (magenta), and H-RasGTPS bound to Sos (green) in a 2:1 Ras:Sos stoichiometry at 18 °C.
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Our observations are thus consistent with a model whereby
binding of Ras at the catalytic site of Sos stabilizes its nucle-
otide-free conformation and primes it for reloading with
GTP (8, 10).
Intriguingly, from our signal perturbation study, it is clear
that addition of SosCat to 15N-labeled H-RasGDP does not
induce any noticeable changes in its 1H,15N correlation spec-
trumwith no noticeable effects on peak positions or line widths
FIGURE 3. Overlay of a representative region of the 1H,15N TROSY spectra of different forms of 15N-labeled H-Ras. A, spectra of H-Ras bound to GDP (blue),
H-RasNF (red), and H-RasNF bound to Sos (green) in a 2:1 stoichiometry recorded at 25 °C. B, spectra of H-RasGDP (blue) and H-RasGDP/Sos (green) in a 2:1 Ras:Sos
stoichiometry recorded at 25 °C. C, comparison among H-RasGDP (blue), H-RasGTPS (magenta), and H-RasGTPS bound to Sos (green) in a 2:1 stoichiometry
recordedat 18 °C.Directionsof representative signal shifts due tonucleotide change fromGDP toGTPSaremarkedwithdashedblackarrows. Directionsof the shifts
that are caused by the subsequent addition of SosCat to H-RasGTPS are marked with dashed red arrows. Spectrally aliased side chain resonances are labeled with
asterisks.
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(Fig. 3B), suggesting that this interaction is very weak andmuch
weaker than the interaction with H-RasNF. The Kd of
H-RasGDP binding with SosCat measured by fluorescence is
only 54 M (Table 1). Our solution NMR data corroborate pre-
vious findings that basal binding of RasGDP with Sos at either
site is relatively weak and would require binding of RasGTP at
the allosteric site to increase the affinity of Sos for RasGDP at
the catalytic site (10, 11). This RasGDP binding contrasts with
RasNF, which can bind to Sos directly even in the absence of
RasGTP (8).
The addition of unlabeled SosCat to a 15N-labeled H-Ras
GTPS sample at a 2:1 Ras:Sos stoichiometry revealed some
significant changes in the TROSY spectrum (Fig. 3C). This pro-
vides evidence that H-RasGTPS is able to bind to Sos with
higher affinity than H-RasGDP and that this increased affinity
is accompanied by significant structural and/or dynamic rear-
rangements for H-Ras. A closer analysis of the signal shift pat-
terns in the NMR spectra of the complexes of Ras with GDP,
GTPS, and GTPS  Sos revealed that change of GDP for
GTP causes significant chemical shift changes for a number of
residues such as Q25, C118, T124, and S145, whereas subse-
quent binding of Sos to RasGTPS shifts its peaks back to posi-
tions similar to those in the free RasGDP (Fig. 3C). This
intriguing observation is difficult to explain definitively based
on available measurements: because of the presence of two dif-
ferent binding sites for Ras on SosCat, it is not clear whether
these signal changes are characteristic of conformational
change upon Ras binding at the allosteric or catalytic sites
and/or exchange between the two. Further experiments, e.g.
using preloading with H-RasY64AGTPS, a mutant that can
only bind to the allosteric site, or using different ratios of com-
ponents as well as using 31P NMR spectroscopy (21–25), may
provide an explanation in the future.
The NMR data presented here clearly show that different
forms of Ras, either nucleotide-free or loaded with GDP or
GTP, bind Sos with different affinities, causing some character-
istic changes in the TROSY spectra of Ras. However, as the
P-loop and Switch I and II regions of Ras have been structurally
shown to be involved in binding at both catalytic and allosteric
sites of Sos (10), it remains challenging to distinguish effects
of binding at these two sites when observing the signal per-
turbations of Ras only. Therefore, to gain better insight into
the site-specific interactions of Ras with Sos, we monitored
the formation of the same complexes using unlabeled Ras
and [13C]methyl-Met,Ile-labeled SosCat.
[13C]Methyl-Met Resonance Assignment of SosCat—To mon-
itor Ras binding at the allosteric and catalytic sites of Sos, we
recorded two-dimensional 1H,13C HMQC spectra of a sample
of SosCat (60M) that was uniformly 13C-labeled (34) at theMet
(-) and Ile (1-)methyl positions (that we call for brevity [13C-
methyl-Met,Ile]SosCat). Themethyl resonances from10 labeled
Met residues occurring in SosCat are well resolved (Fig. 4A),
whereas themethyls from 39 Ile residues suffer from significant
spectral overlap in the HMQC spectra (Fig. 4B). Therefore, we
focused onmethyl-Met signals. To obtain themethyl resonance
assignments, we consecutively substitutedAla forMet, creating
10 mutant forms of Ras: M563A, M567A, M592A, M617A,
M714A, M726A, M824A, M878A, M997A, and M1001A. The
absence of methyl signal in the spectrum of the mutant allows
the assignment for this methionine in the spectrum of the WT
protein (Fig. 5, A and B). Through this comprehensive
mutagenesis approach, eight of the 10Met methyl signals were
unambiguously assigned (Fig. 4A). The spectra of M567A and
M997A yielded no clear changes relative to the WT spectrum,
which, with one unassigned peak remaining, suggests that the
methyl signals from these two residues overlap with each other
and that both contribute to this remaining unassigned peak.
Mapping the position of Met residues onto the crystal struc-
ture of the Ras/Sos complex (10) and relating them to positions
of allosteric and catalytic binding sites (Figs. 4C and 5,C andD),
it is possible to separate signals into groups as originating from
(and presumably primarily reporting on) allosteric (a) and cat-
alytic (c) sites. A third group of Met residues is positioned in
between the sites (a/c) and thus may report on structural
changes in Sos in response to binding at either of these sites. For
convenience, we will indicate the site-specific origin of these
potential reporter signals with corresponding superscripts with
M563(a), M592(a), M617(a), and M726(a) arising from the allos-
teric site of Sos and residues M824(c), M878(c), and M1001(c)
arising from the catalytic site. M714(a)/(c) is positioned in
between the allosteric and catalytic sites and therefore belongs
to the third group. Subsequent titration experiments (see
below) showed that in fact only three of these potential report-
ers, M726(a), M824(c), and M714(a)/(c), display appreciable sen-
sitivity to Ras binding at the allosteric and catalytic sites.
Monitoring NMR Signal Perturbations of SosCat upon Addi-
tion of H-RasNF—To investigate the binding of SosCat to nucle-
otide-free H-Ras, increasing amounts of unlabeled H-RasNF
were added to a sample containing [13C-methyl-Met,Ile]SosCat
(Fig. 6A). The addition ofH-RasNF at higher concentrations, e.g.
above 2:1 Ras:Sos stoichiometry, showed severe broadening for
theM824(c) resonance (Fig. 6A), suggesting that H-RasNF binds
at the catalytic site of SosCat. Furthermore, slight signal broad-
ening was also observed for M714(a)/(c). Residue M714(a)/(c) is
located near the core of Sos and is therefore possibly sensitive to
the conformational and/or dynamic changes induced in Sos
upon H-RasNF binding. Most importantly, residue M726(a)
(which turned out to be the most sensitive probe for binding at
the allosteric site; see below) was largely unperturbed, suggest-
ing that H-RasNF does not bind at the allosteric site. Our site-
specific results therefore indicate that H-RasNF in solution can
only bind to the catalytic site of Sos. This complements previ-
ous crystal studies of H-Ras and Sos (8, 10) showing that nucle-
otide-free H-Ras only ever bound at the catalytic site.
Monitoring Signal Perturbations of SosCat upon H-Ras
GDP Binding—Binding of RasGDP to Sos promotes a basal
level of nucleotide exchange activity that is observed in GDP3
GDP exchange assays (11–13). RasGDP binding to the allo-
steric site is believed to induce weak nucleotide exchange
activity at the catalytic site (11). Here, we explored directly to
which of the sites H-RasGDP binds by adding unlabeled
RasGDP to [13C-methyl-Met,Ile]SosCat. The methyl signals of
Sos M714(a)/(c) and M824(c) are heavily broadened in the
HMQC spectra of 2:1 and 4:1H-RasGDP:Sos samples, whereas
these signals are still visible in the spectrumof a 1:1H-RasGDP:
Sos sample (Fig. 6B). Signal broadening of M714(a)/(c) in Sos
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indicates that H-RasGDP may cause some conformational or
dynamic changes to Sos. Interestingly, M726(a) was not signifi-
cantly perturbed even at 4-fold excess of H-RasGDP, suggest-
ing that RasGDP does not associate noticeably with the allo-
steric site of SosCat. Importantly, the broadening of M824(c)
signal confirms that H-RasGDP binds to the catalytic site (Fig.
6B), suggesting that binding to the catalytic site can occur in the
absence of significant occupancy of the allosteric site. Overall,
the binding is relativelyweak in agreementwith our otherNMR
(Fig. 3B) and fluorescence data (Table 1). Preferential weak
FIGURE 4. Site-specific reporter signals of Sos. Expanded fingerprint regions of the 1H,13C HMQC spectra of 60 M Sos show the region with assigned
[13C]methyl-Met resonances apportioned to allosteric and catalytic sites (A) and the region showing non-assigned [13C]methyl signals of Ile residues as
additional reporter signals (B). C, position of selected Met residues (highlighted in green and labeled individually) in relation to the Ras/Sos crystal structure
(Protein Data Bank code 1NVV). Ras molecules bound at the allosteric and catalytic sites of Sos (gray) are shown in purple and orange, respectively. The
superscripts (a) and (c)mark the proximity of Met residues to the allosteric and catalytic sites, respectively.
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binding of H-RasGDP to the catalytic site of Sos, but not to the
allosteric site, suggests that H-RasGDP is not expected to play
a significant role in activating Sos via allosteric interactions and
that the basal, low level activity of Sos for GDP 3 GDP
exchange in the absence of GTP may be due to inherent weak
binding of RasGDP to the catalytic site only. The role of
DH-PH and histone domains of Sos (11, 32) in further down-
regulating its basal catalytic activity thus may be more subtle
than just sterically blocking the allosteric site for RasGDP (as
well as for RasGTP) binding.
Monitoring Signal Perturbations of SosCat upon H-Ras
GTPS Binding—RasGTPbinding to the allosteric site of Sos is
expected to lead to Sos activation (10), whereas the ability of
RasGTP to bind at the catalytic site of activated Sos has always
been implied in the GTP 3 GTP exchange assays (11, 13).
However, to our knowledge, the latter assumption has not been
tested before. Here, binding between RasGTP and Sos was
monitored in a site-specific manner via the HMQC spectra of
[13C-methyl-Met,Ile]SosCat upon addition of unlabeled
H-RasGTPS. The signals from M726(a), M824(c), and to a
smaller extent M714(a)/(c) shifted in the spectra (Fig. 6C). Resi-
dueM726 from the allosteric site exhibited the largest chemical
shift change. In the crystal structure of the complex, the side
chain of Sos M726(a) is located close to residues I36 and E37
from the Switch I region and Y64 from the Switch II region of
H-Ras (Fig. 5D). Residues M714(a)/(c) and M824(c) also showed
significant signal perturbations and complex signal movement
occurring simultaneously with perturbations at the allosteric
site. Interestingly, close inspection of theM824(c) peak changes
during the titration (Figs. 6C and 7A) reveals that at 1:1 ratio
there are two M824(c) signals observed in slow exchange
between State I (free form) and State II (remodeled form); with
further addition of H-RasGTPS, State I disappears, and the
signal is gradually shifted from State II toward State III (fully
bound) where it remains stable even at higher protein ratios.
This peak movement suggests the existence of complex
dynamic and structural rearrangements at the catalytic site in
response to initial binding at the allosteric site. Although over-
all the initial perturbation to M824(c) appears to be dominated
by conformational changes in response to binding at the allo-
steric site, further gradual signal shifts reveal that there may be
secondary, weaker binding occurring for RasGTP at the cata-
lytic site that is in the fast exchange regime on the chemical shift
time scale. Our fluorescence experiments where binding to the
allosteric site was partially saturated with the addition of
H-RasY64AGTPS (Table 1) concurred with only weak bind-
ing of H-RasGTPS at the catalytic site. In addition to the shift
changes observed on the [13C]methyl of Met, several of the
non-assigned [13C]methyl-Ile resonances were also signifi-
cantly perturbed in the presence of H-RasGTPS (data not
shown). The complex peak movements observed here and the
presence of both slow and fast chemical exchange regimes may
limit the reliability of signal shifts as ameasure of the fraction of
protein bound to the ligand (35), which would complicate esti-
FIGURE5.Anexampleofusingmutagenesis toassignmethyl signalsofMet inSosCat andrelatingMetpositions to thestructure.Overlaysof [13C]methyl
region of 1H,13C HMQC spectra for WT (blue) and mutants (red) M824A (A) and M726A (B) of SosCat. Signals affected by the mutation are enclosed in boxes.
Structures below show reporter groups of Sos in contact with residues of H-Ras. C, structure of the catalytic interface deduced from the crystal structure of
H-RasNF form. H-RasNF (orange) is bound at the catalytic site of Sos (blue). Residue M824(c) (green) forms hydrophobic interactions with H-Ras Y64 (cyan). D,
M726(a) (highlighted in green) interacts with H-Ras at the allosteric site (purple). The figures were produced in PyMOL.
Monitoring Ras-Sos Interactions
JANUARY 22, 2016•VOLUME 291•NUMBER 4 JOURNAL OF BIOLOGICAL CHEMISTRY 1711
 at U
N
IV
ERSITY
 O
F LEED
S on A
pril 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
FIGURE 6. Monitoring changes in the 1H,13C HMQC spectra of SosCat upon the addition of Ras. The Met methyl resonances of SosCat (A–E) (red) and
SosCatW729E (F) (red) were monitored upon the addition of Ras at a Ras:Sos stoichiometry of 0.5:1 (blue), 1:1 (green), 1.5:1 (orange), 2:1 (cyan), 3:1 (purple), and
4:1 (black) in the HMQC spectra. The titrated Ras form is H-RasNF (A), H-RasGDP (B), H-RasGTPS (C), K-RasGTPS (D), K-RasG12VGTPS (E), and H-RasGTPS
(F). Chemical shift perturbations and signal broadening are indicated as black boxes and dashed boxes, respectively. Characteristic states occurring for the
M824(c) signal upon addition of H-RasGTPS are marked in C as I, II, and III.
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mates ofKd values from these signal shifts. Indeed, we could not
obtain a good fit for the dependence of signal shifts on concen-
tration to a single site binding model either for allosteric or for
catalytic site signals. Moreover, because of the low protein con-
centrations used here and the large size of SosCat itself and its
complexeswithH-Ras, the signal-to-noise ratiowas too poor to
quantify signal intensities of methyl signals throughout the
titration (Fig. 7A), which otherwise could have been used to
characterize the exchange regimes further. However, we ran
simulations (Fig. 7, B–D) that show that the signal shift behav-
ior for M824(c) signal can be reasonably recreated for a two-
binding site model with slow and fast exchange regimes. More
accuratemeasurements atmuch higher protein concentrations
and with more experimental points would be required to
extract qualitative information about the exchange rates in this
system. Taken together, the observations by NMR and fluores-
cence suggest that the overall binding of H-RasGTPS to
SosCat is dominatedbybinding at the allosteric site, and its binding
to the catalytic site is much weaker than to the allosteric site.
Monitoring Signal Perturbations of SosCat upon K-Ras
GTPS Binding—To explore whether K-Ras binding to Sos dif-
fers from that of H-Ras, we titrated unlabeled K-RasGTPS
into [13C]methyl-Ile,Met-labeled SosCat. The signals from
M714(a)/(c), M726(a), and M824(c) showed the most significant
changes in the spectrum (Fig. 6D). In addition to the shift
changes observed on the [13C]methyl of Met, several of the
[13C]methyl-Ile residues were also significantly perturbed in
the presence of K-RasGTPS (data not shown). The pattern of
perturbation is comparable with that caused by H-RasGTPS.
However, the slow conformational exchange observed at the
catalytic site in response to occupation of the allosteric site by
H-Ras was not detected for K-Ras binding, suggesting that
FIGURE 7. Consequences of two-site binding and chemical exchange rates for NMR signal shifts and apparent binding constants. A, horizontal slices
through theM824(c) cross-peakof SosCat showing relative spectral changes in the 1Hdimensionuponadditionof the specified equivalents ofH-RasGTPS. The
peakpositions for bindingStates I, II, and III aremarked.B, thermodynamic cycle for two-sitebinding reactionbetween receptor (R) and ligand (L)withplausible
values of Kd and off-rates (koff) used for simulation with LineShapeKin software (35). La and Lc denote ligands bound at the allosteric and catalytic sites,
respectively, andbinding States I, II, and III are labeled accordingly. The simulated spectral traces (with [receptor] fixed at 60M) shown inCmimic qualitatively
the behavior of experimental spectra presented in A. State I corresponds to the chemical shift of free SosCat, state II corresponds to H-RasGTPS bound tightly
(in slow exchange) at the allosteric site, and state III corresponds to a second H-RasGTPSmolecule bindingweakly (in fast exchange) at the catalytic site. The
simulateddependence of the fraction of receptor bound versus the [ligand]:[receptor] (L/R) ratio, however, can be easily fitted into a one-site binding isotherm
(D), which yields an apparent “macroscopic” Kd value of5 M, a value close to that measured for Sos
Cat/H-RasGTPS binding using fluorescence (see
Table 1).
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theremay be subtle differences in how these Ras isoforms affect
the dynamics of Sos and/or slight differences in binding site
affinities. The apparent microscopic Kd value (2 M) esti-
mated from the M726(a) signal shift, which represents
K-RasGTPS binding at the allosteric site, is much lower than
the apparent macroscopic Kd measured by fluorescence for
K-Ras binding to SosCat with the assumption of single site bind-
ing model (Table 1), again suggesting that binding at the allos-
teric site dominates the binding at low ligand concentrations.
Because the chemical shift changes follow the same pattern
upon H-RasGTPS or K-RasGTPS addition to SosCat, it is
likely that SosCat adopts a similar conformation albeit accom-
panied by subtly different dynamic perturbations.
Monitoring Signal Perturbations in SosCat upon K-Ras
G12VGTPS Binding—To examine whether the binding of the
K-RasG12V mutant to SosCat is different in any way from its
wild-type variant, we recorded HMQC spectra of [13C-methyl-
Met,Ile]SosCat upon the addition of unlabeled K-Ras
G12VGTPS. The M824(c) signal in the catalytic site of SosCat
undergoes only a minor shift but does decrease in intensity and
broaden when above equimolar concentrations of K-Ras are
added (Fig. 6E). The signal perturbations for M726(a) in the
allosteric site are less pronounced than those observed with
WTK-Ras, indicating that binding to the allosteric site of Sos is
weaker for the Ras mutant (Fig. 6E). These findings are sup-
ported by the binding measurements obtained from our fluo-
rescence studies, which revealed that the affinity for K-Ras
G12VGTPS binding to Sos (Kd  31 M) was weaker than
that of WT K-Ras (Kd  10 M). This suggests that the G12V
mutant of K-Ras, which is one of the most frequently observed
somatic Ras mutations in cancers, is compromised in its ability
to bind Sos at the allosteric site and activate it compared with
the wild type.
Monitoring Signal Perturbations in W729E Mutant SosCat
upon K-RasG12VGTPS Binding—To characterize the bind-
ing of RasGTP at the catalytic site in the absence of allosteric
activation of Sos, the allosteric site binding can be impaired
through mutation of W729 of SosCat to Glu (W729E) (11).
Upon addition of unlabeled H-RasGTPS to [13C-methyl-
Met,Ile]SosCatW729E, no perturbations were observed for any
of the characteristic signals, includingM726(a), M714(a)/(c), and
M824(c), even when overtitrated (Fig. 6F), suggesting that there
is no detectable binding to either of the binding sites. The fluo-
rescence measurements for this interaction revealed a macro-
scopic Kd of 28 M (Table 1), which may have been dominated
by residual non-optimal binding to the sites away from the
reporter residues used in the NMR. This value is comparable
with theKdof 32Mobtained from fluorescencemeasurements
for the interaction between SosCatW729E and H-RasY64A
GTPS, a combination of mutants that is supposed to block
interactions at both allosteric and catalytic sites. TheNMRdata
overall confirm that the W729E mutation inhibits interaction
with RasGTP at the allosteric site, preventing Sos activation
and further binding of RasGTP at the catalytic site.
Discussion
In our fluorescence-based studies, we monitored the intrin-
sic fluorescence of natively occurringTrp residues in SosCat and
SosHD-DH-PH-Cat upon addition of Ras, which is devoid of fluo-
rophores, to avoid any possibility of perturbing protein struc-
ture or binding activity as may be otherwise expected from
using extrinsic dyes (16). As an orthogonal and complementary
approach, we also usedNMR to report on the details of Ras and
Sos interactions from the viewpoints of both interacting part-
ners in a site-specific manner. Using [13C]methyl NMR probes
for monitoring changes in structure and dynamics is innately
non-perturbative and therefore highly robust (34, 36–38). We
identified three useful SosCat methyl groups in M726(a),
M824(c), andM714(a)/(c), which can be conveniently detected in
well resolved 1H,13C HMQC spectra and which report from
allosteric and catalytic sites as well as from the interface
between them. These signals are sensitive to all aspects (struc-
tural as well as dynamic) of Ras-Sos interaction and can be used
for exploring mechanistic aspects of Sos function in various
complexes. This strategy, applied consistently to a variety of
combinations of different Ras isoforms (K-Ras,H-Ras, and their
selected mutants) in different nucleotide-loaded states (nucle-
otide-free, GDP-loaded, or loaded with GTP analogs) and
different Sos constructs (SosHD-DH-PH-Cat, SosCat, and its
mutants), allowed us to obtain for the first time site-specific
information on the localized binding events at the allosteric and
catalytic sites of Sos.
Taken together, our results are presented schematically in
Fig. 8. The nucleotide-free formofH-Ras (which is not a species
that is significantly populated in isolation in vivo but may use-
fully represent a transition state) binds at the catalytic site only,
affecting only the specific reporter signal M824(c) (Fig. 8A).
Note that in this interaction Sos is not activated due to the lack
of allosteric site binding. The catalytic site binding also leads to
significant signal perturbations in H-RasNF itself. These results
agreewith crystallography studies whereH-RasNF has only ever
been found at the catalytic site of Sos (8, 10). Binding of GDP-
loaded H-Ras to the catalytic site of non-activated SosCat
appears to be much weaker than that of RasNF (Fig. 8B and
Table 1) as judged by signal perturbations on SosCat and Ras.
Importantly, the NMR data suggest that H-RasGDP cannot
bind at the allosteric site strongly enough to achieve significant
activation of Sos; this is in agreement with previous observa-
tions (11) but also suggests that the level of Sos activation by
RasGDP in the recent single molecule studies (13) may have
been overestimated. Weak transient binding of RasGDP at the
catalytic site (even without activation), however, would explain
the modest homonucleotide GDP*3GDP exchange routinely
observed in nucleotide release assays (10, 11, 13).
As expected, H-RasGTPS was found to interact strongly
with the allosteric site of SosCat (Fig. 8C), inducing strong signal
shifts. Unexpectedly, binding of H-RasGTPS at the catalytic
site of fully activated SosCat was only weak and transient. This is
in agreement with the result from saturating the allosteric site
with H-RasY64AGTPS, a mutant that only binds at the allos-
teric site (11, 12), and measuring H-RasGTPS affinity at the
catalytic site using fluorescence. The estimated lower limit of
Kd (21 M) for RasGTPS binding to the catalytic site of
activated Sos is significantly higher than the Kd of H-RasGDP
at the same site (1.9 M) (11). Having a high affinity for
RasGDP, which is the natural substrate for the catalytic reac-
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tion, and low affinity for RasGTP, which is the natural reaction
product, provides a previously underappreciated preferred
direction for the nucleotide exchange reaction,GDP3GTP. In
a situationwhenbothGDPandGTPare present in solution (e.g.
in cytosol), activated Sos would preferentially recognize
RasGDPmolecules with its catalytic site: once the exchange for
GTP is complete, RasGTP would be released due to its lower
affinity. To our knowledge, this is the first suggestion that the
native nucleotide exchange mediated by Sos can have a pre-
ferred directionality and is not just a passive reloading of Ras
molecules with a nucleotide according to the GTP:GDP ratio
present in solution (3).
The NMR mapping experiments performed with K-Ras
revealed results similar to those with H-Ras (Fig. 8D), although
for K-Ras, the slow exchange at the catalytic site was not
detected, andoverall bindingwasweaker (Table 1). The binding
of H-Ras and K-Ras to Sos may therefore be subtly different in
terms of dynamics and affinity despite structural similarities
and very similar nucleotide exchange and hydrolysis properties
(39). Interestingly, the mutation G12V of K-Ras showed sub-
FIGURE 8. Proposed modes of Ras binding to Sos from our NMR assay. A, H-RasNF binds at the catalytic site of Sos and perturbs residues M824(c) and
M714(a)/(c) only (green dots). B, H-RasGDP binding to the catalytic site only slightly perturbs Sos residues M714(a)/(c) and M824(c). Unperturbed signal from Sos
M726(a) is indicated as a black dot. Double-ended arrows indicate weak interactions. C, H-RasGTPS binds at the allosteric site of Sos as confirmed by the
perturbation of residue M726(a). The binding of H-RasGTPS at the allosteric site induces a conformational change to Sos, detected by the perturbation of
residues M714(a)/(c) and M824(c), that allows a second H-RasGTPS to bind weakly to the catalytic site. D, the mechanism for K-RasGTPS is similar to that for
H-RasGTPS. E, K-RasG12VGTPS binds to allosteric and catalytic sites only weakly. F, no Ras binding was observed at both the allosteric and catalytic sites of
SosW729E mutant, which blocks Ras binding to the allosteric site.
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stantially reduced binding to Sos (Table 1). Unlike theWT, the
mutant lacks the ability to induce strong signal perturbations at
the allosteric site of Sos and only weakly binds at allosteric and
catalytic sites (Fig. 8E). Therefore, the G12Vmutant is likely to
be defective in its ability to bind Sos and activate it via allosteric
site binding. Finally, the W729E mutant of SosCat, which is
known to block the interaction with RasGTP at the allosteric
site (11), did not show any signal perturbations either at the
allosteric or catalytic sites upon addition of H-RasGTPS (Fig.
8F), which confirms that in solution binding of RasGTP at the
allosteric site is absolutely required to induce binding of
RasGTP at the catalytic site. Similar results were also obtained
for the SosHD-DH-PH-Cat construct (Table 1), which sterically
occludes the allosteric site.
The lowaffinity binding of RasGTP to the catalytic site of Sos
highlighted in this study may have implications for how nucle-
otide exchange assays mediated by Sos are run and interpreted.
The main scenarios of nucleotide exchange, together with the
consequences of binding at each individual site, are presented
in Fig. 9. For simplicity, additional down-regulation of Ras by
N-terminal domains of Sos occluding the allosteric site (14) is
omitted. Whereas scenario A represents early events in Sos
activation and promoting GDP3 GTP exchange on Ras, sce-
nario B is expected to represent the native, functional GDP3
GTP exchange, which should be the fastest and the most effi-
cient. It relies on strong binding of RasGTP to the allosteric
site, activating Sos; strong binding of RasGDP (the substrate) to
the catalytic site; and fast release of RasGTP (the product) from
FIGURE 9. Common scenarios for nucleotide exchange regimes in Ras/Sos system. The allosteric site is schematically shown at the bottom of Sos and
catalytic site is schematically shownat the top. For each scenario, the stateof the systemandqualitativedescriptionofbindingare shownon the right, including
the expected exchange rate of the nucleotide that was initially bound to incoming Ras. Scenario A corresponds to initial low level activation of Sos when no
RasGTP is present yetwithGDP3GTPexchangedrivenby the excess ofGTPoverGDP in the cytosol. Once enoughRasGTPmolecules areproduced, they lead
to positive feedback activation of Sos (scenario B) where the affinity at the catalytic site is high for RasGDP and low for RasGTP, leading to efficient, native
turnover and expected maximumGDP3 GTP exchange rate. Both nucleotides (GDP andGTP) are present. In scenarios C–E, typical for assays where only
one type of nucleotide is present in excess, a release of labeled nucleotide (marked with *) initially bound to the catalytic site is expected to be slowed down
(relative to the native rate for scenario B) due to either stalling of Sos recycling (scenario C) or the presence of weak binding bottleneck steps at the allosteric
(D) or catalytic site (E).
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the catalytic site once the exchange there is complete. A num-
ber of studies conducted some assays in these conditions (17,
32, 40–42). However, some nucleotide release assays quanti-
fied homonucleotide exchange as a measure of Sos activity and
followed scenarios C–E with each of those suffering from one
or several bottleneck interactions (see Fig. 9) expected to slow
down the apparent rate of nucleotide release or exchange. In
these cases, the activity of Sos as measured by homonucleotide
GDP3GDP or GTP3GTP exchange rates (10, 11, 13, 40, 43)
may be underestimated. Recently, very high heteronucleotide
GDP3 GTP exchange rates of 0.28 s1 were reported in bulk
assays that used non-modified nucleotides and biosensor
detection (41): the S shape of time courses (see Fig. 4A in Ref.
41) is consistent with the initial low level activation quickly
followed by the full activation as is expected from combined
scenarios A and B. Membrane tethering of Ras was shown to
increase the rate of nucleotide exchange 500-fold compared
with the bulk assays (32), but interestingly, the experiments
done by these authors also reveal that the rate of heteronucle-
otide GDP 3 GTP exchange reaction is a further 10 times
faster than homonucleotide GDP3 GDP in the identical con-
ditions, reaching a rate of 5 s1 (see supplemental Fig. 2 in
Ref. 32). Even when Sos was activated by the presence of
RasY64A loadedwith a stable GTP analog, the homonucleotide
exchange reaction rate was much lower (32). The marked
increase in the rates for heteronucleotide exchange was also
consistently observed in the presence of the N-terminal seg-
ment of Sos that down-regulates its activity (32). In another
bulk assay study (40), the rates of SosCat-catalyzed reactions for
mantGDP3GTP andmantGTP3GTP exchanges weremea-
sured. In their study, addition of equimolar SosCat to WT Ras
increased the rates of exchange (relative to the intrinsic rates)
by factors of 112 and 21, respectively, showing that fully acti-
vated SosCat enhances the rate of the heteronucleotide
exchange reaction about 5 times faster than the rate of the
homonucleotideGTP3GTPexchange reaction (seeTable 2 of
Ref. 40). This consistent increase of observed rates for native
heteronucleotide exchange in various previous experiments
can now be explained by the constructive combination of the
stronger (10-fold) binding and activation of Sos by RasGTP
(compared with RasGDP) at the allosteric site (11) and the at
least 10-fold greater binding affinity of the catalytic site for
RasGDP (compared with RasGTP), which was revealed in this
study. Thus, our results and a re-evaluation of previously pub-
lished data suggest that an adequate representation of the
nucleotide exchange catalyzed by Sos in assays may need to
preferably measure the GDP3GTP exchange reaction and be
conducted in the presence of both RasGTP (to activate Sos)
and RasGDP (as the native substrate for the catalytic conver-
sion to RasGTP) and in the presence of an excess of GTP or its
analog.
In conclusion, from our NMR Ras-Sos interaction assay
developed and presented here and experiments on different Ras
forms, we were able to disentangle nucleotide-dependent Ras
binding at the allosteric and catalytic sites of Sos. To achieve a
fully functional heterotrimeric complex with Sos, e.g. to study
its functioning mechanism, both GDP- and GTP-loaded Ras
molecules should be present. Our solution studies fully support
previously proposed mechanism for positive feedback activa-
tion of Sos (10) but also suggest that the extent of such activa-
tionmayhave been previously underestimatedwhen the homo-
nucleotide exchange rate was measured. The NMR approach
described here opens new avenues throughwhich to investigate
this complex process directly in more detail in the future. Sim-
ilarly, further NMR experiments can shed light on the molecu-
lar level structural and dynamic detail of the processes involved
in self-activating Sos by Ras (13). The site-specific interaction
assay presented here may also aid the development and screen-
ing of future drugs designed against Ras-Sos interactions at par-
ticular sites of Sos (44).
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